✦ LIBER ✦

Comparison of the efficacy, safety and predictive value of HIV genotyping using distinct ritonavir-boosted protease inhibitors

✍ Scribed by Pablo Barreiro; Nuria Camino; Carmen de Mendoza; Luisa Valer; Marina Núñez; Luz Martı́n-Carbonero; Juan González-Lahoz; Vincent Soriano

Book ID: 119563536
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 109 KB
Volume: 20
Category: Article
ISSN: 0924-8579
DOI: 10.1016/s0924-8579(02)00250-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of a dual boosted pr

Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population

✍ Stefano Rusconi, Vania Giacomet, Chiara Mameli, Alessandra Viganò, Ottavia Vigan 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 259 KB

A Short-Term Study of the Safety, Pharma

A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 Protease

✍ Danner, Sven A.; Carr, Andrew; Leonard, John M.; Lehman, Leah M.; Gudiol, France 📂 Article 📅 1995 🏛 Massachusetts Medical Society 🌐 English ⚖ 122 KB

A meta-analysis of the efficacy and safe

A meta-analysis of the efficacy and safety of unboosted atazanavir compared with ritonavir-boosted protease inhibitor maintenance therapy in HIV-infected adults with established virological suppression after induction

✍ Baril, J; Conway, B; Giguère, P; Ferko, N; Hollmann, S; Angel, JB 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 725 KB

Efficacy and tolerability of a double bo

Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors

✍ P Chetchotisakd; S Anunnatsiri; P Mootsikapun; S Kiertiburanakul; T Anekthananon 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

A randomized study investigating the eff

A randomized study investigating the efficacy and safety of amprenavir in combination with low-dose ritonavir in protease inhibitor-experienced HIV-infected adults

✍ F Pulido; C Katlama; M Marquez; R Thomas; N Clumeck; R De J Pedro; AM Cattelan; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Hill A, Moyle G. Relative antiviral effi

Hill A, Moyle G. Relative antiviral efficacy of ritonavir-boosted darunavir and ritonavir-boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trials. HIV Med 2007; 8: 259–264 : Methodological accuracy in cross-trial comparisons of antiretroviral regimens in multitreated patients

✍ Drs JM Llibre; N Pérez-Alvarez 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB